About Sickkids
About SickKids

Peter Kannu, MB ChB (Otago), PhD, DCH, FRACP

The Hospital for Sick Children
Staff Physician
Clinical and Metabolic Genetics

Research Institute
Associate Scientist
Developmental & Stem Cell Biology

University of Toronto
Assistant Professor

Phone: (416) 813-7654 Ext. 5340
Fax: (416) 813-5345
e-mail: peter.kannu@sickkids.ca

Brief Biography

Peter Kannu is a Clinical Geneticist at The Hospital for Sick Children and an investigator at the SickKids Research Institute. His special area of expertise is in the inherited disorders of the skeleton that cause short stature, arthritis and osteoporosis. He also provides genetic counseling for children affected by inherited skin disorders and Neurofibromatosis type 1.

Peter graduated from The University of Otago in 1994, and went on to complete his specialty training in paediatrics, and then in clinical genetics. His post-graduate qualifications include: Fellowship of the Royal Australasian College of Physicians, Clinical Geneticist of the Human Genetics Society of Australasia (HGSA), Postgraduate Diploma in Child Health and a PhD from the University of Melbourne. At the SickKids Research Institute, Peter continues his research into rare human conditions causing disorders of the skeleton. He is currently working on identifying causes of cartilage cell damage which lead to osteoarthritis.

Clinical Care Activities

Dr. Kannu's clinical care activities include the genetic assessment of short stature, childhood osteoarthritis and osteoporosis, Neurofibromatosis and inherited skin disorders.

Research Activities

  •  Neurofibromatosis type 1
  • Juvenile idiopathic osteoporosis
  • Skeletal dysplasias
  • Osteoarthritis
  • Cartilage injury

Selected Publications

Paraspinal ganglioneuroma in the proband of a large family with mild cutaneous manifestations of NF1, carrying a deep NF1 intronic mutation. Kannu P, Nour M, Irving M, Xie J, Loder D, Lai J, Islam O, MacKenzie J, Messiaen L. Clin Genet. 2013. 83(2):191-4

The Molecular Genetics of Arthritis: A Role for the Wnt Pathway and Human Type II Collagen Mutations. Kannu P. University of Melbourne. 2011.

Osteoarthritis as the Presenting Pathology in Patients with Skeletal Dysplasias. Kannu P, S. R., Bateman J. Journal of Clinical Rheumatology and Musculoskeletal Medicine. 2010.

Trisomy 16 mosaicism at chorionic villus sampling and amniocentesis with a normal physical and intellectual outcome. Coman D, Gardner RJ, Pertile MD, Kannu P. Fetal Diagn Ther. 2010. 28(2):117-8.

Employing molecular genetics of chondrodysplasias to inform the study of osteoarthritis.
Kannu P
, Bateman JF, Belluoccio D, Fosang AJ, Savarirayan R. Arthritis Rheum. 2009. 60(2):325-34.

Premature arthritis is a distinct type II collagen phenotype. Kannu P, Bateman JF, Randle S, Cowie S, du Sart D, McGrath S, Edwards M, Savarirayan R. Arthritis Rheum. 2010 62(5):1421-30.

Rapp-Hodgkin ectodermal dysplasia syndrome: the clinical and molecular overlap with Hay-Wells syndrome. Kannu P, Savarirayan R, Ozoemena L, White SM, McGrath JA.
Am J Med Genet A. 2006. 140(8):887-91.